Table 3 Comparison of the lipoprotein profile assessed by HNMR-1 between SLE and MI groups from METAINFLAMMATION cohort.
Outcomes | Metabolic syndrome (MI) (n = 85) | Lupus erythematosus systemic (SLE) (n = 66) | P value |
|---|---|---|---|
VLDL-C (mg/dL) | 16.4 (8.7) | 13.8 (8.9) | 0.07 |
IDL-C (mg/dL) | 11.4 (3.7) | 9.7 (3.9) | 0.007 |
LDL C (mg/dL) | 121.9 (27.9) | 115.1 (25.9) | 0.12 |
HDL-C (mg/dL) | 52.1 (16.3) | 58.1 (11.2) | 0.02 |
VLDL-TG (mg/dL) | 72.4 (30.3) | 56.5 (28.1) | 0.001 |
IDL-TG (mg/dL) | 12.2 (3.0) | 10.6 (3.3) | 0.002 |
LDL-TG (mg/dL) | 16.1 (4.2) | 15.8 (4.7) | 0.78 |
HDL-TG (mg/dL) | 16.0 (4.7) | 15.6 (5.8) | 0.65 |
VLDL-P (nmol/L) | 52.6 (22.9) | 41.1 (20.7) | 0.001 |
Large VLDL-P (nmol/L) | 1.4 (0.5) | 1.1 (0.4) | 0.003 |
Medium VLDL-P (nmol/L) | 5.1 (2.3) | 4.7 (2.8) | 0.42 |
Small VLDL-P (nmol/L) | 46.1 (20.4) | 35.2 (17.5) | < 0.001 |
LDL-P (nmol/L) | 1236.9 (260.4) | 1135.4 (232.1) | 0.01 |
Large LDL-P (nmol/L) | 185.3 (39.9) | 192.8 (36.5) | 0.23 |
Medium LDL-P (nmol/L) | 377.3 (123.3) | 361.9 (119.1) | 0.44 |
Small LDL-P (nmol/L) | 674.3 (126.1) | 580.6 (98.4) | < 0.001 |
HDL-P (μmol/L) | 28.2 (4.2) | 27.6 (5.3) | 0.49 |
Large HDL-P (μmol/L) | 0.28 (0.03) | 0.29 (0.04) | 0.20 |
Médium HDL-P (μmol/L) | 9.4 (1.6) | 10.8 (2.3) | < 0.001 |
Small HDL-P (μmol/L) | 18.5 (3.5) | 16.5 (4.1) | 0.001 |
